Matsui, H., Terashima, T., Mizuno, T., Masaki, Y., Ueno, M., Tsuji, K., Kumanishi, R., Hirooka, Y., Suzuki, R., Sugimoto, R., Umemoto, K., Sato, A., Ando, T., Unno, M., Masui, T., Eguchi, H., Yoshimura, K., Hatano, E., Nagano, H., Ioka, T. (2026). A randomized phase III study of gemcitabine plus cisplatin with S-1 versus gemcitabine plus cisplatin with immune checkpoint inhibitor in unresectable biliary tract cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps4252